US stocks rose broadly Tuesday and the S&P 500 pushed toward another record high as investors focused on a bullish assortment of reflation libations. Markets also cheered when they heard Janet Yellen's voice in an official capacity again, with the former and well-respected Fed Chair accepting President-elect Biden's offer to join his economic team in the official capacity as the incoming US Treasury Secretary.
Markets are trading off their inter-session highs but remain on stimulus watch. However, caution should be exercised; after all, we’ve had this stimulus carrot dangled in front of us before.
Still, it was one of those healthy risk-on days that may have set the market's wheels in motion for a December to remember. The better sentiment came amid robust global manufacturing PMIs for November (notably in China) and optimism that coronavirus vaccines could soon help usher in a faster global economic recovery, with the Moderna candidate applying for FDA emergency approval. Still, the cherry on top is the possibility of stimulus before year-end, helping rocket-fuel the reflationary tone to markets.
The next leg of the rotation into the reopen trade is underway as rates move higher, a December to remember kicks off, and stimulus hopes grow. Price action overnight is yet another confirmation that folks are willing to look yonder and beyond the bounds of lockdowns (forced or self-imposed) and instead are eager to focus on a vivid post-vaccine world.
Santa has come early for the markets, even if it is a very unusual version of consumer Christmas-lite this year. Regardless, it’s "happy days are here again" and the world will be hoping the festive mood music never ends.
Still, I’d be surprised if the move today at the index level turns into a straight line higher for the Value/Cyclical trade. Instead, I’d expect more single-stock dispersion again as investors become more selective.
The cross-currents of positive vaccine news and an improving outlook vs. slowing data and weaker sentiment kept the VIX in a 21-25 range for three weeks, even as the S&P 500 tested the upper end of its recent range and the Russell 2000 surged 20% in November. The VIX fell below 21 during the Thanksgiving holiday week, but the belly (approximate 3-6-month VIX futures) has remained stable at about 25 as growth/virus risks persist.
With various moving parts to manage and some justifiable fatigue setting in among OPEC+ policymakers attempting to find common ground to extend historically high production curtailments, the OPEC/OPEC+ process is proving to be an exceptionally delicate affair. And even if we compromise to defuse a bitter dispute over the current quota cuts, it does not bode well for the OPEC compliance cooperative in 2021.
The timing could not have been worse for OPEC+ to drop the ball, given the moon shoot reflationary unfolding in what could very well be the start of a December to remember. While cross-assets are reveling to the beat of vaccine and stimulus news, oil markets are still languishing in OPEC + meeting deferment sulk.
And rubbing salt in the OPEC+ fissures, oil sold off further as US inventories balloon. Analysts penciled their Thanksgiving oil demand guesses on the wrong side of the ledger; the American Petroleum Institute reported on Tuesday a build in crude oil inventories of 4.146 million barrels for the week ending November 27, against analysts' expectations for a draw.
Oil prices were trading down on Tuesday afternoon before the API's data release – despite daily news of Covid-19 vaccine progress – after OPEC on Monday ended its meeting without a resolution. OPEC finds itself in a slippery situation again—and make no mistake, it’s compulsory for them to present a united front for whatever plan it hatches. The small slip in oil price on Tuesday is only a curtain warmer of what will happen to prices should the deal fail. Indeed, it’s worth keeping an eye on oil markets while the wrangling over OPEC+ production cuts continues.
The Euro surged higher overnight on an assortment of reflation libations that rocket-fuelled the global growth upswing narrative, specifically early vaccine approvals and US stimulus optimism. And Fed hopes came off the ropes after a weaker than expected ISM overnight.
Also, have Brexit negotiations gone into the 'tunnel'? Times reporter Tom Newton-Dunn says they have, although there hasn’t been confirmation from other sources yet. For now, it should be treated with caution, particularly as this still does not mean the political hurdles will be overcome. What’s clear is that the most decisive few days now lie ahead. On both sides, general assumptions are that a deal needs to be done by next week's EU Summit on December 11/12, so there’s still room for a calamitous tumble, but it’s more unlikely than not.
The pound also caught a bid, with gilts under renewed pressure after the headlines on Brexit negotiations. Along with discussions around some additional stimulus in the US, it looks like the potential pitfalls that could have tripped up markets into year-end are suddenly looking less of a worry.
So, after the month-end noise, EURUSD sliced through 2020 highs like a hot knife through butter. The FX insider track has the same views as last week, namely that the market is under-invested and the risk is a bigger move higher.
The Australian Dollar
Today, the Australian dollar is in a bit of catch-up mode after RBA Governor Lowe, speaking to the economic committee, reiterated that "Australia has turned the corner on the economy".
The AUD had failed to keep pace with other parts of G10, failing to make much progress despite a risk-on mood in stock. I suspect the escalating Australia–China trade spat is creating a touch of buyer fatigue. Yesterday, EUR-USD failed to hold above 1.20, USD-CAD was unable to break below support at 1.1920, and AUD-USD could not sustain the shift above 0.74. All three currencies weakened against the USD as a result, but while the EUR and CAD have recovered the bulk of that reversal, the AUD languished
Solid manufacturing PMIs in Asia for November fusing with stimulus and vaccine optimism drove broad-based FX gains in Asia. Central banks in the region are increasingly uncomfortable with FX strength, but their caution is not unusual early in a global economic cycle. Relatively attractive yields vs. G10 suggest investment flow into local bond and equity markets will continue.
The offshore yuan rose to a one week high after the dollar slumped to a two-year low and mainland shares climbed on hopes that a vaccine and a fresh round of US stimulus will boost global growth in 2021.
However, the ringgit has fallen off the pace as local traders turn a cautious eye to the OPEC quota extension meeting proceedings, which are now presenting a crater on the road instead of a minor speed bump. During the OPEC conference, tension saw the Saudi Energy minister offer to resign as co-chair of the panel at one point. Yesterday it was reported that the scheduled meeting would be pushed back to December 3 to give ministers more time to reach an agreement over production.
Gold popped back above USD1,800/oz as USD retreated. And while gold can go a bit higher, it still faces uphill challenges from vaccine optimism.
After a series of nasty declines following enthusiasm over Covid-19 vaccines, gold had been trading well below USD1,800/oz and came close to testing the psychological make or break for ETF concerns at the USD1,750/oz level. A weaker USD effectively threw a lifeline around bullion, helping it rally back from two weeks of declines.
For more market insights, follow me on Twitter: @Steveinnes123
The information is not to be construed as a recommendation; or an offer to buy or sell; or the solicitation of an offer to buy or sell any security, financial product, or instrument; or to participate in any trading strategy. Readers should seek their own advice. Reproduction or redistribution of this information is not permitted.
With equity markets rising to fresh record highs in the United States and Europe, risk appetite is rising again